Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Assets    
Financing receivables $ 395,562 $ 347,871
Investments 91,277 91,964
Financing receivables and investments held-for-sale   27,971
Securitization assets 5,617 6,144
Cash and cash equivalents 39,575 31,846
Restricted cash and cash equivalents 43,061 49,865
Intangible assets, net 1,655 1,706
Goodwill 3,798 3,798
Other assets 9,835 10,267
Total Assets 590,380 571,432
Liabilities and Equity    
Accounts payable, dividends payable and accrued expenses 8,486 7,296
Deferred funding obligations 64,801 74,675
Credit facility 117,143 77,114
Asset-backed nonrecourse notes (secured by financing receivables of $108.4 million and $109.5 million, respectively) 98,742 100,081
Other nonrecourse debt (secured by financing receivables of $147.3 million and $156.4 million, respectively) 150,706 159,843
Deferred tax liability   1,799
Total Liabilities 439,878 420,808
Non-controlling interest redeemable for cash 3,120  
Equity:    
Preferred stock value      
Common stock value 159 159
Additional paid in capital 160,648 160,120
Retained deficit (14,738) (13,864)
Accumulated other comprehensive income 97 110
Non-controlling interest 1,216 4,099
Total Equity 147,382 150,624
Total Liabilities and Equity $ 590,380 $ 571,432